SA's vaccine manufacturing capability has received another boost as local biopharmaceutical company Biovac becomes part of an international agreement to produce an oral cholera vaccine that will benefit
mostly African countries...You’ve always trusted us to help you navigate the world. Support the Sunday Times by becoming a premium member for only R80 and keep the conversation going. You can cancel anytime.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: